Vantage Financial Partners (Illinois)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,910
Closed -$213K 86
2020
Q3
$213K Buy
1,910
+75
+4% +$8.41K 0.13% 71
2020
Q2
$205K Buy
+1,835
New +$181K 0.13% 69

Other funds holding XBI

Vantage Financial Partners (Illinois)'s XBI Position: Q4 2020 in Review

Vantage Financial Partners (Illinois) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2020, closing a stake of 1,910 shares — an estimated $213K sold.

Vantage Financial Partners (Illinois) first reported a position in XBI in Q2 2020 and held it in 2 quarters. The position peaked at $213K in Q3 2020. 654 funds tracked by Wall St. Rank hold XBI as of Q4 2020.

  • Vantage Financial Partners (Illinois) reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2020 after selling out during the quarter.
  • Vantage Financial Partners (Illinois) sold 1,910 State Street SPDR S&P Biotech ETF shares in Q4 2020, an estimated $213K.
  • Vantage Financial Partners (Illinois) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 2 quarters.
  • Vantage Financial Partners (Illinois)'s State Street SPDR S&P Biotech ETF position peaked at $213K in Q3 2020.
  • 654 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2020.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q4 2020, filed 5 Feb 2021.